SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Dr. Juan Manuel Pérez - 20 April, 2026 0

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 17 April, 2026 0

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 16 April, 2026 0

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: Ostial Lesion

Intrastent Restenosis in Ostial Lesions in the Right Coronary Artery: Predictors...

Últimas Noticias

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Noticias Institucionales

Fellow’s Corner – Case 1: Chronic Total Occlusion Treated via Retrograde Approach. A True Challenge

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

Accesos